Grifols (GRFS) Operating Income (2010 - 2020)
Grifols (GRFS) posted Operating Income of $1.0 billion for Q1 2020, down 65.5% quarter-over-quarter from $2.9 billion in Q4 2019, and up 7.09% year-on-year from $937.7 million in Q2 2019.
Grifols (GRFS) Operating Income (2010 - 2020) Analysis & Trends
Grifols (GRFS) has reported Operating Income for 10 consecutive years, with $1.0 billion the latest figure, recorded in Q1 2020.
- Operating Income for Q1 2020 came in at $1.0 billion, up 7.09% year-over-year; the trailing twelve-month figure through Mar 2020 was $7.5 billion (up 79.3% YoY), and the FY2025 annual result was $1.4 billion, up 13.59% from the prior year.
- Operating Income was $1.0 billion for Q1 2020 at Grifols, down from $2.9 billion in the prior quarter.
- Over five years, Operating Income peaked at $2.9 billion in Q4 2019 and troughed at $249.9 million in Q2 2016.
- Average Operating Income over 5 years is $986.8 million, with a median of $313.5 million recorded in 2017.
- Year-over-year, Operating Income slumped 37.89% in 2016 and soared 494.17% in 2017.
- Over 5 years, Operating Income stood at $488.8 million in 2016, then jumped by 494.17% to $2.9 billion in 2017, then declined by 10.0% to $2.6 billion in 2018, then advanced by 11.36% to $2.9 billion in 2019, then slumped by 65.5% to $1.0 billion in 2020.
- Per Business Quant data, the three most recent Operating Income figures were $1.0 billion in Q1 2020, $2.9 billion in Q4 2019, and $937.7 million in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 9.50 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 6.36 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.99 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 4.25 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -7.73 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 2.67 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 2.59 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | -6.71 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 1.00 Bn |
| Dec 31, 2019 | 2.91 Bn |
| Mar 31, 2019 | 937.75 Mn |
| Dec 31, 2018 | 252.39 Mn |
| Sep 30, 2018 | 310.27 Mn |
| Jun 30, 2018 | 312.31 Mn |
| Mar 31, 2018 | 300.50 Mn |
| Dec 31, 2017 | 944.89 Mn |
| Jun 30, 2017 | 313.51 Mn |
| Mar 31, 2017 | 269.23 Mn |
| Dec 31, 2016 | 488.79 Mn |
| Sep 30, 2016 | 267.29 Mn |
| Jun 30, 2016 | 249.95 Mn |
| Mar 31, 2016 | 255.35 Mn |
| Dec 31, 2015 | 787.01 Mn |
| Sep 30, 2015 | 275.09 Mn |
| Jun 30, 2015 | 258.96 Mn |
| Mar 31, 2015 | 267.09 Mn |
| Dec 31, 2014 | 788.89 Mn |
| Sep 30, 2014 | 283.89 Mn |